ICARES Medicus, Inc. (TPEX:6612)
Taiwan · Delayed Price · Currency is TWD 104.50
-0.50 (-0.48%)
Sep 4, 2025, 1:24 PM CST
ICARES Medicus Market Cap
ICARES Medicus has a market cap or net worth of 4.89 billion as of September 4, 2025. Its market cap has decreased by -26.00% in one year.
Market Cap
4.89B
Enterprise Value
5.08B
Revenue
1.08B
Ranking
n/a
PE Ratio
47.44
Stock Price
104.50
Market Cap Chart
Since December 27, 2016, ICARES Medicus's market cap has increased from 1.51B to 4.89B, an increase of 222.99%. That is a compound annual growth rate of 14.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 4.89B | -7.30% |
| Dec 31, 2024 | 5.28B | 6.98% |
| Dec 29, 2023 | 4.93B | 77.87% |
| Dec 30, 2022 | 2.77B | 18.70% |
| Dec 30, 2021 | 2.34B | 11.21% |
| Dec 31, 2020 | 2.10B | -28.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 359.06B |
| PharmaEssentia | 170.30B |
| Bora Pharmaceuticals Co., LTD. | 90.35B |
| Lotus Pharmaceutical | 50.76B |
| Lumosa Therapeutics | 37.82B |
| Oneness Biotech | 37.54B |
| Polaris Group | 29.16B |
| Center Laboratories | 28.56B |